Addendum No. 2 to Supply Contract, dated August 19, 2021, by and between Isoray Medical, Inc. and Joint Stock Company

Contract Categories: Business Finance - Stock Agreements
EX-10.1 2 ex_278782.htm EXHIBIT 10.1 ex_158570.htm

Exhibit 10.1


Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.


Addendum No. 2 dated 2021.08.16 to

Contract No. 840/08625142/31/22-21

Date of signature: 2021.03.18



Isotope - Regional Alliance, Joint-Stock Company (Isotope JSC)


Pogodinskaya str., 22, Moscow, 119435, Russia.

Phone: +7(495) 981-96-16



The Company Isoray Medical Inc.

350 Hills Street, Suite 106

Richland, WA ###-###-#### USA


THE BUYER and THE SELLERS have mutually agreed about the following:


The following company is determined by the Buyer as a Supplier of the Goods, produced by JSC "SSC RIAR": MedikorPharma-Ural LLC, 620109,  Sverdlovskaya region, Yekaterinburg, Krulya Street, 2, apartment 192, Tel.:  8(343) 270-75-29, E-mail: ***@***. The Buyer is responsible to the Seller for MedikorPharma-Ural LLC fulfillment of its obligations. The cost of services, provided by MedikorPharma-Ural LLC, shall not exceed USD [**] [**].


The present addendum is the integral part of contract 840/08625142/31/22-21 and may be signed by E-mail.


All other terms and conditions are in accordance with Contract No. 840/08625142/31/22-21, Appendices 1 and 2, Addendum 1.


/s/ Konstantin Ershov             /s/ Jonathan Hunt              
Konstantin Ershov   Jonathan Hunt   
19 Aug 2021     19 Aug 2021  
Head of Sales Department, JSC Isotope   Isoray - CFO